Medical Care
Global Covid-19 Treatment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 28, 25
- ID: 344247
- Pages: 155
- Figures: 152
- Views: 1
In 2024, the global market size of Covid-19 Treatment was estimated to be worth US$ 1574 million and is forecast to reach approximately US$ 3.3 million by 2031 with a CAGR of -59.3% during the forecast period 2025-2031.
Patients today have more treatment options in the battle against coronavirus disease.
In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.
The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.
The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.
In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.
In this report, we study all treatment method for Covid-19.
Global core covid-19 treatment manufacturers include Cadila Healthcare, Novartis etc.The top 2 companies hold a share about 30%.North America is the largest market, with a share about 47%, followed by Europe and Asia Pacific with the share about 30% and 9%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Covid-19 Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Treatment.
The Covid-19 Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Covid-19 Treatment market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Cadila Healthcare
Johnson & Johnson
ImmunoPrecise
Novartis
AstraZeneca
Cipla
AbbVie
Bayer
Regeneron Pharmaceuticals
Ascletis Pharma
GlaxoSmithKline
Gilead Sciences
Pharmstandard
Fujifilm Holdings
Zhejiang Hisun Pharmaceutical Co. Ltd
Roche
Sanofi
Pfizer
Eli Lilly
Segment by Type
Life Support
Antiviral Medicine
Antibody Treatments
Others
Segment by End User
Children
Adult
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Covid-19 Treatment in global and regional level.
Chapter 3: Detailed analysis of Covid-19 Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Covid-19 Treatment revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by End User, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by End User and by country, revenue for each segment.
Chapter 8: Europe by Type, by End User and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by End User and by region, revenue for each segment.
Chapter 10: Latin America by Type, by End User and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by End User and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Patients today have more treatment options in the battle against coronavirus disease.
In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.
The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.
The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.
In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.
In this report, we study all treatment method for Covid-19.
Global core covid-19 treatment manufacturers include Cadila Healthcare, Novartis etc.The top 2 companies hold a share about 30%.North America is the largest market, with a share about 47%, followed by Europe and Asia Pacific with the share about 30% and 9%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Covid-19 Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Treatment.
The Covid-19 Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Covid-19 Treatment market comprehensively. Regional market sizes, concerning products by Type, by End User, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Cadila Healthcare
Johnson & Johnson
ImmunoPrecise
Novartis
AstraZeneca
Cipla
AbbVie
Bayer
Regeneron Pharmaceuticals
Ascletis Pharma
GlaxoSmithKline
Gilead Sciences
Pharmstandard
Fujifilm Holdings
Zhejiang Hisun Pharmaceutical Co. Ltd
Roche
Sanofi
Pfizer
Eli Lilly
Segment by Type
Life Support
Antiviral Medicine
Antibody Treatments
Others
Segment by End User
Children
Adult
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Covid-19 Treatment in global and regional level.
Chapter 3: Detailed analysis of Covid-19 Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Covid-19 Treatment revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by End User, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by End User and by country, revenue for each segment.
Chapter 8: Europe by Type, by End User and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by End User and by region, revenue for each segment.
Chapter 10: Latin America by Type, by End User and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by End User and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Covid-19 Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Covid-19 Treatment Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Life Support
1.2.3 Antiviral Medicine
1.2.4 Antibody Treatments
1.2.5 Others
1.3 Market by End User
1.3.1 Global Covid-19 Treatment Market Size Growth Rate by End User (2020 VS 2024 VS 2031)
1.3.2 Children
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Covid-19 Treatment Market Size Estimates and Forecasts
2.2 Covid-19 Treatment Market Size by Region: 2024 Versus 2031
2.2.1 Global Covid-19 Treatment Revenue by Region: 2020-2025
2.2.2 Global Covid-19 Treatment Revenue Forecast by Region (2026-2031)
2.2.3 Global Covid-19 Treatment Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Covid-19 Treatment Revenue by Type (2020-2031)
3.1.2 Global Covid-19 Treatment Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by End User
3.2.1 Global Covid-19 Treatment Revenue by End User (2020-2031)
3.2.2 Global Covid-19 Treatment Revenue Market Share by End User (2020-2031)
3.3 by Type and by End User Crossing Analysis
3.3.1 Life Support of Covid-19 Treatment Revenue Market Share by End User
3.3.2 Antiviral Medicine of Covid-19 Treatment Revenue Market Share by End User
3.3.3 Antibody Treatments of Covid-19 Treatment Revenue Market Share by End User
3.3.4 Others of Covid-19 Treatment Revenue Market Share by End User
4 Global Covid-19 Treatment by Company
4.1 Global Covid-19 Treatment Revenue by Company (2020-2025)
4.2 Global Covid-19 Treatment Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Covid-19 Treatment Companies around the World: Ranking by Revenue
4.3.2 Global Covid-19 Treatment Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Covid-19 Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Covid-19 Treatment Companies Headquarters & Product Type
4.4.1 Global Covid-19 Treatment Companies Headquarters
4.4.2 Date of International Companies Enter into Covid-19 Treatment Market
4.4.3 Global Covid-19 Treatment Companies Product & Service
4.4.4 Life Support Revenue Market Share of Covid-19 Treatment by Company
4.4.5 Antiviral Medicine Revenue Market Share of Covid-19 Treatment by Company
4.4.6 Antibody Treatments Revenue Market Share of Covid-19 Treatment by Company
4.4.7 Others Revenue Market Share of Covid-19 Treatment by Company
4.5 Global Covid-19 Treatment Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Cadila Healthcare
5.1.1 Cadila Healthcare Corporation Information
5.1.2 Cadila Healthcare Description, Business Overview
5.1.3 Cadila Healthcare Covid-19 Treatment Products Offered
5.1.4 Cadila Healthcare Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.1.5 Cadila Healthcare Covid-19 Treatment Revenue by Product in 2024
5.1.6 Cadila Healthcare Covid-19 Treatment Revenue by End User in 2024
5.1.7 Cadila Healthcare Covid-19 Treatment Revenue by Geographic Area in 2024
5.1.8 Cadila Healthcare Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Corporation Information
5.2.2 Johnson & Johnson Description, Business Overview
5.2.3 Johnson & Johnson Covid-19 Treatment Products Offered
5.2.4 Johnson & Johnson Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.2.5 Johnson & Johnson Covid-19 Treatment Revenue by Product in 2024
5.2.6 Johnson & Johnson Covid-19 Treatment Revenue by End User in 2024
5.2.7 Johnson & Johnson Covid-19 Treatment Revenue by Geographic Area in 2024
5.2.8 Johnson & Johnson Recent Developments
5.3 ImmunoPrecise
5.3.1 ImmunoPrecise Corporation Information
5.3.2 ImmunoPrecise Description, Business Overview
5.3.3 ImmunoPrecise Covid-19 Treatment Products Offered
5.3.4 ImmunoPrecise Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.3.5 ImmunoPrecise Covid-19 Treatment Revenue by Product in 2024
5.3.6 ImmunoPrecise Covid-19 Treatment Revenue by End User in 2024
5.3.7 ImmunoPrecise Covid-19 Treatment Revenue by Geographic Area in 2024
5.3.8 ImmunoPrecise Recent Developments
5.4 Novartis
5.4.1 Novartis Corporation Information
5.4.2 Novartis Description, Business Overview
5.4.3 Novartis Covid-19 Treatment Products Offered
5.4.4 Novartis Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.4.5 Novartis Covid-19 Treatment Revenue by Product in 2024
5.4.6 Novartis Covid-19 Treatment Revenue by End User in 2024
5.4.7 Novartis Covid-19 Treatment Revenue by Geographic Area in 2024
5.4.8 Novartis Recent Developments
5.5 AstraZeneca
5.5.1 AstraZeneca Corporation Information
5.5.2 AstraZeneca Description, Business Overview
5.5.3 AstraZeneca Covid-19 Treatment Products Offered
5.5.4 AstraZeneca Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.5.5 AstraZeneca Covid-19 Treatment Revenue by Product in 2024
5.5.6 AstraZeneca Covid-19 Treatment Revenue by End User in 2024
5.5.7 AstraZeneca Covid-19 Treatment Revenue by Geographic Area in 2024
5.5.8 AstraZeneca Recent Developments
5.6 Cipla
5.6.1 Cipla Corporation Information
5.6.2 Cipla Description, Business Overview
5.6.3 Cipla Covid-19 Treatment Products Offered
5.6.4 Cipla Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.6.5 Cipla Covid-19 Treatment Revenue by Product in 2024
5.6.6 Cipla Covid-19 Treatment Revenue by End User in 2024
5.6.7 Cipla Covid-19 Treatment Revenue by Geographic Area in 2024
5.6.8 Cipla Recent Developments
5.7 AbbVie
5.7.1 AbbVie Corporation Information
5.7.2 AbbVie Description, Business Overview
5.7.3 AbbVie Covid-19 Treatment Products Offered
5.7.4 AbbVie Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.7.5 AbbVie Covid-19 Treatment Revenue by Product in 2024
5.7.6 AbbVie Covid-19 Treatment Revenue by End User in 2024
5.7.7 AbbVie Covid-19 Treatment Revenue by Geographic Area in 2024
5.7.8 AbbVie Recent Developments
5.8 Bayer
5.8.1 Bayer Corporation Information
5.8.2 Bayer Description, Business Overview
5.8.3 Bayer Covid-19 Treatment Products Offered
5.8.4 Bayer Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.8.5 Bayer Covid-19 Treatment Revenue by Product in 2024
5.8.6 Bayer Covid-19 Treatment Revenue by End User in 2024
5.8.7 Bayer Covid-19 Treatment Revenue by Geographic Area in 2024
5.8.8 Bayer Recent Developments
5.9 Regeneron Pharmaceuticals
5.9.1 Regeneron Pharmaceuticals Corporation Information
5.9.2 Regeneron Pharmaceuticals Description, Business Overview
5.9.3 Regeneron Pharmaceuticals Covid-19 Treatment Products Offered
5.9.4 Regeneron Pharmaceuticals Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.9.5 Regeneron Pharmaceuticals Covid-19 Treatment Revenue by Product in 2024
5.9.6 Regeneron Pharmaceuticals Covid-19 Treatment Revenue by End User in 2024
5.9.7 Regeneron Pharmaceuticals Covid-19 Treatment Revenue by Geographic Area in 2024
5.9.8 Regeneron Pharmaceuticals Recent Developments
5.10 Ascletis Pharma
5.10.1 Ascletis Pharma Corporation Information
5.10.2 Ascletis Pharma Description, Business Overview
5.10.3 Ascletis Pharma Covid-19 Treatment Products Offered
5.10.4 Ascletis Pharma Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.10.5 Ascletis Pharma Covid-19 Treatment Revenue by Product in 2024
5.10.6 Ascletis Pharma Covid-19 Treatment Revenue by End User in 2024
5.10.7 Ascletis Pharma Covid-19 Treatment Revenue by Geographic Area in 2024
5.10.8 Ascletis Pharma Recent Developments
5.11 GlaxoSmithKline
5.11.1 GlaxoSmithKline Corporation Information
5.11.2 GlaxoSmithKline Description, Business Overview
5.11.3 GlaxoSmithKline Covid-19 Treatment Products Offered
5.11.4 GlaxoSmithKline Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.11.5 GlaxoSmithKline Covid-19 Treatment Revenue by Product in 2024
5.11.6 GlaxoSmithKline Covid-19 Treatment Revenue by End User in 2024
5.11.7 GlaxoSmithKline Covid-19 Treatment Revenue by Geographic Area in 2024
5.11.8 GlaxoSmithKline Recent Developments
5.12 Gilead Sciences
5.12.1 Gilead Sciences Corporation Information
5.12.2 Gilead Sciences Description, Business Overview
5.12.3 Gilead Sciences Covid-19 Treatment Products Offered
5.12.4 Gilead Sciences Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.12.5 Gilead Sciences Covid-19 Treatment Revenue by Product in 2024
5.12.6 Gilead Sciences Covid-19 Treatment Revenue by End User in 2024
5.12.7 Gilead Sciences Covid-19 Treatment Revenue by Geographic Area in 2024
5.12.8 Gilead Sciences Recent Developments
5.13 Pharmstandard
5.13.1 Pharmstandard Corporation Information
5.13.2 Pharmstandard Description, Business Overview
5.13.3 Pharmstandard Covid-19 Treatment Products Offered
5.13.4 Pharmstandard Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.13.5 Pharmstandard Covid-19 Treatment Revenue by Product in 2024
5.13.6 Pharmstandard Covid-19 Treatment Revenue by End User in 2024
5.13.7 Pharmstandard Covid-19 Treatment Revenue by Geographic Area in 2024
5.13.8 Pharmstandard Recent Developments
5.14 Fujifilm Holdings
5.14.1 Fujifilm Holdings Corporation Information
5.14.2 Fujifilm Holdings Description, Business Overview
5.14.3 Fujifilm Holdings Covid-19 Treatment Products Offered
5.14.4 Fujifilm Holdings Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.14.5 Fujifilm Holdings Covid-19 Treatment Revenue by Product in 2024
5.14.6 Fujifilm Holdings Covid-19 Treatment Revenue by End User in 2024
5.14.7 Fujifilm Holdings Covid-19 Treatment Revenue by Geographic Area in 2024
5.14.8 Fujifilm Holdings Recent Developments
5.15 Zhejiang Hisun Pharmaceutical Co. Ltd
5.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Corporation Information
5.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Description, Business Overview
5.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Products Offered
5.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue by Product in 2024
5.15.6 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue by End User in 2024
5.15.7 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue by Geographic Area in 2024
5.15.8 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments
5.16 Roche
5.16.1 Roche Corporation Information
5.16.2 Roche Description, Business Overview
5.16.3 Roche Covid-19 Treatment Products Offered
5.16.4 Roche Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.16.5 Roche Covid-19 Treatment Revenue by Product in 2024
5.16.6 Roche Covid-19 Treatment Revenue by End User in 2024
5.16.7 Roche Covid-19 Treatment Revenue by Geographic Area in 2024
5.16.8 Roche Recent Developments
5.17 Sanofi
5.17.1 Sanofi Corporation Information
5.17.2 Sanofi Description, Business Overview
5.17.3 Sanofi Covid-19 Treatment Products Offered
5.17.4 Sanofi Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.17.5 Sanofi Covid-19 Treatment Revenue by Product in 2024
5.17.6 Sanofi Covid-19 Treatment Revenue by End User in 2024
5.17.7 Sanofi Covid-19 Treatment Revenue by Geographic Area in 2024
5.17.8 Sanofi Recent Developments
5.18 Pfizer
5.18.1 Pfizer Corporation Information
5.18.2 Pfizer Description, Business Overview
5.18.3 Pfizer Covid-19 Treatment Products Offered
5.18.4 Pfizer Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.18.5 Pfizer Covid-19 Treatment Revenue by Product in 2024
5.18.6 Pfizer Covid-19 Treatment Revenue by End User in 2024
5.18.7 Pfizer Covid-19 Treatment Revenue by Geographic Area in 2024
5.18.8 Pfizer Recent Developments
5.19 Eli Lilly
5.19.1 Eli Lilly Corporation Information
5.19.2 Eli Lilly Description, Business Overview
5.19.3 Eli Lilly Covid-19 Treatment Products Offered
5.19.4 Eli Lilly Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.19.5 Eli Lilly Covid-19 Treatment Revenue by Product in 2024
5.19.6 Eli Lilly Covid-19 Treatment Revenue by End User in 2024
5.19.7 Eli Lilly Covid-19 Treatment Revenue by Geographic Area in 2024
5.19.8 Eli Lilly Recent Developments
6 North America
6.1 North America Covid-19 Treatment Market Size YoY Growth 2020-2031
6.2 North America Covid-19 Treatment Market Facts & Figures by Country (2020-2031)
6.3 North America Covid-19 Treatment Revenue by Type (2020-2025)
6.4 North America Covid-19 Treatment Revenue by End User (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Covid-19 Treatment Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Covid-19 Treatment Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Covid-19 Treatment Revenue by Type (2020-2025)
7.4 Asia-Pacific Covid-19 Treatment Revenue by End User (2020-2025)
8 Europe
8.1 Europe Covid-19 Treatment Market Size YoY Growth 2020-2031
8.2 Europe Covid-19 Treatment Market Facts & Figures by Country (2020-2031)
8.3 Europe Covid-19 Treatment Revenue by Type (2020-2025)
8.4 Europe Covid-19 Treatment Revenue by End User (2020-2025)
9 Latin America
9.1 Latin America Covid-19 Treatment Market Size YoY Growth 2020-2031
9.2 Latin America Covid-19 Treatment Market Facts & Figures by Country (2020-2031)
9.3 Latin America Covid-19 Treatment Revenue by Type (2020-2025)
9.4 Latin America Covid-19 Treatment Revenue by End User (2020-2025)
10 Middle East and Africa
10.1 Latin America Covid-19 Treatment Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Covid-19 Treatment Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Covid-19 Treatment Revenue by Type (2020-2025)
10.4 Middle East and Africa Covid-19 Treatment Revenue by End User (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Covid-19 Treatment Supply Chain Analysis
11.2 Covid-19 Treatment Key Raw Materials and Upstream Suppliers
11.3 Covid-19 Treatment Clients Analysis
11.4 Covid-19 Treatment Sales Channel and Sales Model Analysis
11.4.1 Covid-19 Treatment Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Covid-19 Treatment Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Covid-19 Treatment Distributors
12 Covid-19 Treatment Market Dynamics
12.1 Covid-19 Treatment Industry Trends
12.2 Covid-19 Treatment Market Drivers
12.3 Covid-19 Treatment Market Challenges
12.4 Covid-19 Treatment Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Covid-19 Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Covid-19 Treatment Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Life Support
1.2.3 Antiviral Medicine
1.2.4 Antibody Treatments
1.2.5 Others
1.3 Market by End User
1.3.1 Global Covid-19 Treatment Market Size Growth Rate by End User (2020 VS 2024 VS 2031)
1.3.2 Children
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Covid-19 Treatment Market Size Estimates and Forecasts
2.2 Covid-19 Treatment Market Size by Region: 2024 Versus 2031
2.2.1 Global Covid-19 Treatment Revenue by Region: 2020-2025
2.2.2 Global Covid-19 Treatment Revenue Forecast by Region (2026-2031)
2.2.3 Global Covid-19 Treatment Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Covid-19 Treatment Revenue by Type (2020-2031)
3.1.2 Global Covid-19 Treatment Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by End User
3.2.1 Global Covid-19 Treatment Revenue by End User (2020-2031)
3.2.2 Global Covid-19 Treatment Revenue Market Share by End User (2020-2031)
3.3 by Type and by End User Crossing Analysis
3.3.1 Life Support of Covid-19 Treatment Revenue Market Share by End User
3.3.2 Antiviral Medicine of Covid-19 Treatment Revenue Market Share by End User
3.3.3 Antibody Treatments of Covid-19 Treatment Revenue Market Share by End User
3.3.4 Others of Covid-19 Treatment Revenue Market Share by End User
4 Global Covid-19 Treatment by Company
4.1 Global Covid-19 Treatment Revenue by Company (2020-2025)
4.2 Global Covid-19 Treatment Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Covid-19 Treatment Companies around the World: Ranking by Revenue
4.3.2 Global Covid-19 Treatment Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Covid-19 Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Covid-19 Treatment Companies Headquarters & Product Type
4.4.1 Global Covid-19 Treatment Companies Headquarters
4.4.2 Date of International Companies Enter into Covid-19 Treatment Market
4.4.3 Global Covid-19 Treatment Companies Product & Service
4.4.4 Life Support Revenue Market Share of Covid-19 Treatment by Company
4.4.5 Antiviral Medicine Revenue Market Share of Covid-19 Treatment by Company
4.4.6 Antibody Treatments Revenue Market Share of Covid-19 Treatment by Company
4.4.7 Others Revenue Market Share of Covid-19 Treatment by Company
4.5 Global Covid-19 Treatment Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Cadila Healthcare
5.1.1 Cadila Healthcare Corporation Information
5.1.2 Cadila Healthcare Description, Business Overview
5.1.3 Cadila Healthcare Covid-19 Treatment Products Offered
5.1.4 Cadila Healthcare Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.1.5 Cadila Healthcare Covid-19 Treatment Revenue by Product in 2024
5.1.6 Cadila Healthcare Covid-19 Treatment Revenue by End User in 2024
5.1.7 Cadila Healthcare Covid-19 Treatment Revenue by Geographic Area in 2024
5.1.8 Cadila Healthcare Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Corporation Information
5.2.2 Johnson & Johnson Description, Business Overview
5.2.3 Johnson & Johnson Covid-19 Treatment Products Offered
5.2.4 Johnson & Johnson Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.2.5 Johnson & Johnson Covid-19 Treatment Revenue by Product in 2024
5.2.6 Johnson & Johnson Covid-19 Treatment Revenue by End User in 2024
5.2.7 Johnson & Johnson Covid-19 Treatment Revenue by Geographic Area in 2024
5.2.8 Johnson & Johnson Recent Developments
5.3 ImmunoPrecise
5.3.1 ImmunoPrecise Corporation Information
5.3.2 ImmunoPrecise Description, Business Overview
5.3.3 ImmunoPrecise Covid-19 Treatment Products Offered
5.3.4 ImmunoPrecise Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.3.5 ImmunoPrecise Covid-19 Treatment Revenue by Product in 2024
5.3.6 ImmunoPrecise Covid-19 Treatment Revenue by End User in 2024
5.3.7 ImmunoPrecise Covid-19 Treatment Revenue by Geographic Area in 2024
5.3.8 ImmunoPrecise Recent Developments
5.4 Novartis
5.4.1 Novartis Corporation Information
5.4.2 Novartis Description, Business Overview
5.4.3 Novartis Covid-19 Treatment Products Offered
5.4.4 Novartis Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.4.5 Novartis Covid-19 Treatment Revenue by Product in 2024
5.4.6 Novartis Covid-19 Treatment Revenue by End User in 2024
5.4.7 Novartis Covid-19 Treatment Revenue by Geographic Area in 2024
5.4.8 Novartis Recent Developments
5.5 AstraZeneca
5.5.1 AstraZeneca Corporation Information
5.5.2 AstraZeneca Description, Business Overview
5.5.3 AstraZeneca Covid-19 Treatment Products Offered
5.5.4 AstraZeneca Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.5.5 AstraZeneca Covid-19 Treatment Revenue by Product in 2024
5.5.6 AstraZeneca Covid-19 Treatment Revenue by End User in 2024
5.5.7 AstraZeneca Covid-19 Treatment Revenue by Geographic Area in 2024
5.5.8 AstraZeneca Recent Developments
5.6 Cipla
5.6.1 Cipla Corporation Information
5.6.2 Cipla Description, Business Overview
5.6.3 Cipla Covid-19 Treatment Products Offered
5.6.4 Cipla Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.6.5 Cipla Covid-19 Treatment Revenue by Product in 2024
5.6.6 Cipla Covid-19 Treatment Revenue by End User in 2024
5.6.7 Cipla Covid-19 Treatment Revenue by Geographic Area in 2024
5.6.8 Cipla Recent Developments
5.7 AbbVie
5.7.1 AbbVie Corporation Information
5.7.2 AbbVie Description, Business Overview
5.7.3 AbbVie Covid-19 Treatment Products Offered
5.7.4 AbbVie Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.7.5 AbbVie Covid-19 Treatment Revenue by Product in 2024
5.7.6 AbbVie Covid-19 Treatment Revenue by End User in 2024
5.7.7 AbbVie Covid-19 Treatment Revenue by Geographic Area in 2024
5.7.8 AbbVie Recent Developments
5.8 Bayer
5.8.1 Bayer Corporation Information
5.8.2 Bayer Description, Business Overview
5.8.3 Bayer Covid-19 Treatment Products Offered
5.8.4 Bayer Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.8.5 Bayer Covid-19 Treatment Revenue by Product in 2024
5.8.6 Bayer Covid-19 Treatment Revenue by End User in 2024
5.8.7 Bayer Covid-19 Treatment Revenue by Geographic Area in 2024
5.8.8 Bayer Recent Developments
5.9 Regeneron Pharmaceuticals
5.9.1 Regeneron Pharmaceuticals Corporation Information
5.9.2 Regeneron Pharmaceuticals Description, Business Overview
5.9.3 Regeneron Pharmaceuticals Covid-19 Treatment Products Offered
5.9.4 Regeneron Pharmaceuticals Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.9.5 Regeneron Pharmaceuticals Covid-19 Treatment Revenue by Product in 2024
5.9.6 Regeneron Pharmaceuticals Covid-19 Treatment Revenue by End User in 2024
5.9.7 Regeneron Pharmaceuticals Covid-19 Treatment Revenue by Geographic Area in 2024
5.9.8 Regeneron Pharmaceuticals Recent Developments
5.10 Ascletis Pharma
5.10.1 Ascletis Pharma Corporation Information
5.10.2 Ascletis Pharma Description, Business Overview
5.10.3 Ascletis Pharma Covid-19 Treatment Products Offered
5.10.4 Ascletis Pharma Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.10.5 Ascletis Pharma Covid-19 Treatment Revenue by Product in 2024
5.10.6 Ascletis Pharma Covid-19 Treatment Revenue by End User in 2024
5.10.7 Ascletis Pharma Covid-19 Treatment Revenue by Geographic Area in 2024
5.10.8 Ascletis Pharma Recent Developments
5.11 GlaxoSmithKline
5.11.1 GlaxoSmithKline Corporation Information
5.11.2 GlaxoSmithKline Description, Business Overview
5.11.3 GlaxoSmithKline Covid-19 Treatment Products Offered
5.11.4 GlaxoSmithKline Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.11.5 GlaxoSmithKline Covid-19 Treatment Revenue by Product in 2024
5.11.6 GlaxoSmithKline Covid-19 Treatment Revenue by End User in 2024
5.11.7 GlaxoSmithKline Covid-19 Treatment Revenue by Geographic Area in 2024
5.11.8 GlaxoSmithKline Recent Developments
5.12 Gilead Sciences
5.12.1 Gilead Sciences Corporation Information
5.12.2 Gilead Sciences Description, Business Overview
5.12.3 Gilead Sciences Covid-19 Treatment Products Offered
5.12.4 Gilead Sciences Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.12.5 Gilead Sciences Covid-19 Treatment Revenue by Product in 2024
5.12.6 Gilead Sciences Covid-19 Treatment Revenue by End User in 2024
5.12.7 Gilead Sciences Covid-19 Treatment Revenue by Geographic Area in 2024
5.12.8 Gilead Sciences Recent Developments
5.13 Pharmstandard
5.13.1 Pharmstandard Corporation Information
5.13.2 Pharmstandard Description, Business Overview
5.13.3 Pharmstandard Covid-19 Treatment Products Offered
5.13.4 Pharmstandard Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.13.5 Pharmstandard Covid-19 Treatment Revenue by Product in 2024
5.13.6 Pharmstandard Covid-19 Treatment Revenue by End User in 2024
5.13.7 Pharmstandard Covid-19 Treatment Revenue by Geographic Area in 2024
5.13.8 Pharmstandard Recent Developments
5.14 Fujifilm Holdings
5.14.1 Fujifilm Holdings Corporation Information
5.14.2 Fujifilm Holdings Description, Business Overview
5.14.3 Fujifilm Holdings Covid-19 Treatment Products Offered
5.14.4 Fujifilm Holdings Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.14.5 Fujifilm Holdings Covid-19 Treatment Revenue by Product in 2024
5.14.6 Fujifilm Holdings Covid-19 Treatment Revenue by End User in 2024
5.14.7 Fujifilm Holdings Covid-19 Treatment Revenue by Geographic Area in 2024
5.14.8 Fujifilm Holdings Recent Developments
5.15 Zhejiang Hisun Pharmaceutical Co. Ltd
5.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Corporation Information
5.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Description, Business Overview
5.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Products Offered
5.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue by Product in 2024
5.15.6 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue by End User in 2024
5.15.7 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue by Geographic Area in 2024
5.15.8 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments
5.16 Roche
5.16.1 Roche Corporation Information
5.16.2 Roche Description, Business Overview
5.16.3 Roche Covid-19 Treatment Products Offered
5.16.4 Roche Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.16.5 Roche Covid-19 Treatment Revenue by Product in 2024
5.16.6 Roche Covid-19 Treatment Revenue by End User in 2024
5.16.7 Roche Covid-19 Treatment Revenue by Geographic Area in 2024
5.16.8 Roche Recent Developments
5.17 Sanofi
5.17.1 Sanofi Corporation Information
5.17.2 Sanofi Description, Business Overview
5.17.3 Sanofi Covid-19 Treatment Products Offered
5.17.4 Sanofi Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.17.5 Sanofi Covid-19 Treatment Revenue by Product in 2024
5.17.6 Sanofi Covid-19 Treatment Revenue by End User in 2024
5.17.7 Sanofi Covid-19 Treatment Revenue by Geographic Area in 2024
5.17.8 Sanofi Recent Developments
5.18 Pfizer
5.18.1 Pfizer Corporation Information
5.18.2 Pfizer Description, Business Overview
5.18.3 Pfizer Covid-19 Treatment Products Offered
5.18.4 Pfizer Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.18.5 Pfizer Covid-19 Treatment Revenue by Product in 2024
5.18.6 Pfizer Covid-19 Treatment Revenue by End User in 2024
5.18.7 Pfizer Covid-19 Treatment Revenue by Geographic Area in 2024
5.18.8 Pfizer Recent Developments
5.19 Eli Lilly
5.19.1 Eli Lilly Corporation Information
5.19.2 Eli Lilly Description, Business Overview
5.19.3 Eli Lilly Covid-19 Treatment Products Offered
5.19.4 Eli Lilly Covid-19 Treatment Revenue and Gross Margin (2020-2025)
5.19.5 Eli Lilly Covid-19 Treatment Revenue by Product in 2024
5.19.6 Eli Lilly Covid-19 Treatment Revenue by End User in 2024
5.19.7 Eli Lilly Covid-19 Treatment Revenue by Geographic Area in 2024
5.19.8 Eli Lilly Recent Developments
6 North America
6.1 North America Covid-19 Treatment Market Size YoY Growth 2020-2031
6.2 North America Covid-19 Treatment Market Facts & Figures by Country (2020-2031)
6.3 North America Covid-19 Treatment Revenue by Type (2020-2025)
6.4 North America Covid-19 Treatment Revenue by End User (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Covid-19 Treatment Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Covid-19 Treatment Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Covid-19 Treatment Revenue by Type (2020-2025)
7.4 Asia-Pacific Covid-19 Treatment Revenue by End User (2020-2025)
8 Europe
8.1 Europe Covid-19 Treatment Market Size YoY Growth 2020-2031
8.2 Europe Covid-19 Treatment Market Facts & Figures by Country (2020-2031)
8.3 Europe Covid-19 Treatment Revenue by Type (2020-2025)
8.4 Europe Covid-19 Treatment Revenue by End User (2020-2025)
9 Latin America
9.1 Latin America Covid-19 Treatment Market Size YoY Growth 2020-2031
9.2 Latin America Covid-19 Treatment Market Facts & Figures by Country (2020-2031)
9.3 Latin America Covid-19 Treatment Revenue by Type (2020-2025)
9.4 Latin America Covid-19 Treatment Revenue by End User (2020-2025)
10 Middle East and Africa
10.1 Latin America Covid-19 Treatment Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Covid-19 Treatment Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Covid-19 Treatment Revenue by Type (2020-2025)
10.4 Middle East and Africa Covid-19 Treatment Revenue by End User (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Covid-19 Treatment Supply Chain Analysis
11.2 Covid-19 Treatment Key Raw Materials and Upstream Suppliers
11.3 Covid-19 Treatment Clients Analysis
11.4 Covid-19 Treatment Sales Channel and Sales Model Analysis
11.4.1 Covid-19 Treatment Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Covid-19 Treatment Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Covid-19 Treatment Distributors
12 Covid-19 Treatment Market Dynamics
12.1 Covid-19 Treatment Industry Trends
12.2 Covid-19 Treatment Market Drivers
12.3 Covid-19 Treatment Market Challenges
12.4 Covid-19 Treatment Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Covid-19 Treatment Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Covid-19 Treatment Market Size Growth by End User (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Covid-19 Treatment Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Covid-19 Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Covid-19 Treatment Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Covid-19 Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Covid-19 Treatment Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Covid-19 Treatment Revenue by End User (2020-2025) & (US$ Million)
Table 9. Global Covid-19 Treatment Revenue Forecast by End User (2026-2031) & (US$ Million)
Table 10. Covid-19 Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 11. Covid-19 Treatment Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Covid-19 Treatment Players by Revenue (US$ Million) in 2024
Table 13. Global Covid-19 Treatment Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Covid-19 Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Treatment as of 2024)
Table 15. Global Covid-19 Treatment Companies Headquarters
Table 16. Date of International Companies Enter into Covid-19 Treatment Market
Table 17. Global Covid-19 Treatment Companies Product & Service
Table 18. Global Covid-19 Treatment Mergers & Acquisitions, Expansion Plans
Table 19. Cadila Healthcare Corporation Information
Table 20. Cadila Healthcare Description and Business Overview
Table 21. Cadila Healthcare Covid-19 Treatment Product
Table 22. Cadila Healthcare Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Cadila Healthcare Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 24. Cadila Healthcare Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 25. Cadila Healthcare Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 26. Cadila Healthcare Recent Developments
Table 27. Johnson & Johnson Corporation Information
Table 28. Johnson & Johnson Description and Business Overview
Table 29. Johnson & Johnson Covid-19 Treatment Product
Table 30. Johnson & Johnson Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Johnson & Johnson Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 32. Johnson & Johnson Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 33. Johnson & Johnson Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 34. Johnson & Johnson Recent Developments
Table 35. ImmunoPrecise Corporation Information
Table 36. ImmunoPrecise Description and Business Overview
Table 37. ImmunoPrecise Covid-19 Treatment Product
Table 38. ImmunoPrecise Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. ImmunoPrecise Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 40. ImmunoPrecise Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 41. ImmunoPrecise Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 42. ImmunoPrecise Recent Developments
Table 43. Novartis Corporation Information
Table 44. Novartis Description and Business Overview
Table 45. Novartis Covid-19 Treatment Product
Table 46. Novartis Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Novartis Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 48. Novartis Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 49. Novartis Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 50. Novartis Recent Developments
Table 51. AstraZeneca Corporation Information
Table 52. AstraZeneca Description and Business Overview
Table 53. AstraZeneca Covid-19 Treatment Product
Table 54. AstraZeneca Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. AstraZeneca Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 56. AstraZeneca Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 57. AstraZeneca Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 58. AstraZeneca Recent Developments
Table 59. Cipla Corporation Information
Table 60. Cipla Description and Business Overview
Table 61. Cipla Covid-19 Treatment Product
Table 62. Cipla Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Cipla Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 64. Cipla Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 65. Cipla Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 66. Cipla Recent Developments
Table 67. AbbVie Corporation Information
Table 68. AbbVie Description and Business Overview
Table 69. AbbVie Covid-19 Treatment Product
Table 70. AbbVie Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. AbbVie Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 72. AbbVie Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 73. AbbVie Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 74. AbbVie Recent Developments
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Covid-19 Treatment Product
Table 78. Bayer Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Bayer Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 80. Bayer Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 81. Bayer Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 82. Bayer Recent Developments
Table 83. Regeneron Pharmaceuticals Corporation Information
Table 84. Regeneron Pharmaceuticals Description and Business Overview
Table 85. Regeneron Pharmaceuticals Covid-19 Treatment Product
Table 86. Regeneron Pharmaceuticals Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Regeneron Pharmaceuticals Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 88. Regeneron Pharmaceuticals Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 89. Regeneron Pharmaceuticals Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 90. Regeneron Pharmaceuticals Recent Developments
Table 91. Ascletis Pharma Corporation Information
Table 92. Ascletis Pharma Description and Business Overview
Table 93. Ascletis Pharma Covid-19 Treatment Product
Table 94. Ascletis Pharma Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Ascletis Pharma Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 96. Ascletis Pharma Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 97. Ascletis Pharma Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 98. Ascletis Pharma Recent Developments
Table 99. GlaxoSmithKline Corporation Information
Table 100. GlaxoSmithKline Description and Business Overview
Table 101. GlaxoSmithKline Covid-19 Treatment Product
Table 102. GlaxoSmithKline Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. GlaxoSmithKline Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 104. GlaxoSmithKline Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 105. GlaxoSmithKline Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 106. GlaxoSmithKline Recent Developments
Table 107. Gilead Sciences Corporation Information
Table 108. Gilead Sciences Description and Business Overview
Table 109. Gilead Sciences Covid-19 Treatment Product
Table 110. Gilead Sciences Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Gilead Sciences Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 112. Gilead Sciences Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 113. Gilead Sciences Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 114. Gilead Sciences Recent Developments
Table 115. Pharmstandard Corporation Information
Table 116. Pharmstandard Description and Business Overview
Table 117. Pharmstandard Covid-19 Treatment Product
Table 118. Pharmstandard Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Pharmstandard Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 120. Pharmstandard Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 121. Pharmstandard Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 122. Pharmstandard Recent Developments
Table 123. Fujifilm Holdings Corporation Information
Table 124. Fujifilm Holdings Description and Business Overview
Table 125. Fujifilm Holdings Covid-19 Treatment Product
Table 126. Fujifilm Holdings Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Fujifilm Holdings Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 128. Fujifilm Holdings Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 129. Fujifilm Holdings Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 130. Fujifilm Holdings Recent Developments
Table 131. Zhejiang Hisun Pharmaceutical Co. Ltd Corporation Information
Table 132. Zhejiang Hisun Pharmaceutical Co. Ltd Description and Business Overview
Table 133. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product
Table 134. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 136. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 137. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 138. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments
Table 139. Roche Corporation Information
Table 140. Roche Description and Business Overview
Table 141. Roche Covid-19 Treatment Product
Table 142. Roche Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Roche Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 144. Roche Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 145. Roche Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 146. Roche Recent Developments
Table 147. Sanofi Corporation Information
Table 148. Sanofi Description and Business Overview
Table 149. Sanofi Covid-19 Treatment Product
Table 150. Sanofi Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Sanofi Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 152. Sanofi Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 153. Sanofi Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 154. Sanofi Recent Developments
Table 155. Pfizer Corporation Information
Table 156. Pfizer Description and Business Overview
Table 157. Pfizer Covid-19 Treatment Product
Table 158. Pfizer Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Pfizer Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 160. Pfizer Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 161. Pfizer Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 162. Pfizer Recent Developments
Table 163. Eli Lilly Corporation Information
Table 164. Eli Lilly Description and Business Overview
Table 165. Eli Lilly Covid-19 Treatment Product
Table 166. Eli Lilly Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 167. Eli Lilly Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 168. Eli Lilly Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 169. Eli Lilly Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 170. Eli Lilly Recent Developments
Table 171. North America Covid-19 Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 172. North America Covid-19 Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 173. North America Covid-19 Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 174. North America Covid-19 Treatment Revenue by End User (2020-2025) & (US$ Million)
Table 175. Asia-Pacific Covid-19 Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 176. Asia-Pacific Covid-19 Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 177. Asia-Pacific Covid-19 Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 178. Asia-Pacific Covid-19 Treatment Revenue by End User (2020-2025) & (US$ Million)
Table 179. Europe Covid-19 Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 180. Europe Covid-19 Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 181. Europe Covid-19 Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 182. Europe Covid-19 Treatment Revenue by End User (2020-2025) & (US$ Million)
Table 183. Latin America Covid-19 Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 184. Latin America Covid-19 Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 185. Latin America Covid-19 Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 186. Latin America Covid-19 Treatment Revenue by End User (2020-2025) & (US$ Million)
Table 187. Middle East and Africa Covid-19 Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 188. Middle East and Africa Covid-19 Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 189. Middle East and Africa Covid-19 Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 190. Middle East and Africa Covid-19 Treatment Revenue by End User (2020-2025) & (US$ Million)
Table 191. Covid-19 Treatment Key Raw Materials, Industry Status and Trend
Table 192. Covid-19 Treatment Key Raw Materials and Upstream Suppliers
Table 193. Covid-19 Treatment Clients Status and Trend
Table 194. Covid-19 Treatment Typical Clients
Table 195. Covid-19 Treatment Distributors
Table 196. Covid-19 Treatment Market Trends
Table 197. Covid-19 Treatment Market Drivers
Table 198. Covid-19 Treatment Market Challenges
Table 199. Covid-19 Treatment Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Covid-19 Treatment Product Picture
Figure 2. Global Covid-19 Treatment Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Covid-19 Treatment Revenue Market Share by Type in 2024 & 2031
Figure 4. Life Support Product Picture
Figure 5. Antiviral Medicine Product Picture
Figure 6. Antibody Treatments Product Picture
Figure 7. Others Product Picture
Figure 8. Global Covid-19 Treatment Market Size by End User (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Covid-19 Treatment Revenue Market Share by End User in 2024 & 2031
Figure 10. Children
Figure 11. Adult
Figure 12. Covid-19 Treatment Report Years Considered
Figure 13. Global Covid-19 Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Covid-19 Treatment Market Size (2020-2031) & (US$ Million)
Figure 15. Global Covid-19 Treatment Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Covid-19 Treatment Revenue Market Share by Region (2020-2031)
Figure 17. Global Covid-19 Treatment Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Covid-19 Treatment Revenue Market Share Forecast by End User (2020-2031)
Figure 19. Life Support of Covid-19 Treatment Revenue Market Share by End User, 2024 VS 2031
Figure 20. Antiviral Medicine of Covid-19 Treatment Revenue Market Share by End User, 2024 VS 2031
Figure 21. Antibody Treatments of Covid-19 Treatment Revenue Market Share by End User, 2024 VS 2031
Figure 22. Others of Covid-19 Treatment Revenue Market Share by End User, 2024 VS 2031
Figure 23. Covid-19 Treatment Revenue Share by Company (2024)
Figure 24. Covid-19 Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Life Support Revenue Proportion by Company in 2024
Figure 26. Antiviral Medicine Revenue Proportion by Company in 2024
Figure 27. Antibody Treatments Revenue Proportion by Company in 2024
Figure 28. Others Revenue Proportion by Company in 2024
Figure 29. North America Covid-19 Treatment Revenue 2020-2031 (US$ Million)
Figure 30. North America Covid-19 Treatment Revenue Market Share by Type (2020-2025)
Figure 31. North America Covid-19 Treatment Revenue Market Share by End User (2020-2025)
Figure 32. Asia-Pacific Covid-19 Treatment Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Covid-19 Treatment Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Covid-19 Treatment Revenue Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Covid-19 Treatment Revenue Market Share by End User (2020-2025)
Figure 36. Europe Covid-19 Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Covid-19 Treatment Revenue Market Share by Country (2020-2031)
Figure 38. Europe Covid-19 Treatment Revenue Market Share by Type (2020-2025)
Figure 39. Europe Covid-19 Treatment Revenue Market Share by End User (2020-2025)
Figure 40. Latin America Covid-19 Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Latin America Covid-19 Treatment Revenue Market Share by Country (2020-2031)
Figure 42. Latin America Covid-19 Treatment Revenue Market Share by Type (2020-2025)
Figure 43. Latin America Covid-19 Treatment Revenue Market Share by End User (2020-2025)
Figure 44. Middle East and Africa Covid-19 Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Middle East and Africa Covid-19 Treatment Revenue Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Covid-19 Treatment Revenue Market Share by Type (2020-2025)
Figure 47. Middle East and Africa Covid-19 Treatment Revenue Market Share by End User (2020-2025)
Figure 48. Covid-19 Treatment Supply Chain (Upstream and Downstream Market)
Figure 49. Global Production Market Share of Covid-19 Treatment Raw Materials by Region in 2024
Figure 50. Covid-19 Treatment Distribution Channels
Figure 51. Global Covid-19 Treatment Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 52. Global Covid-19 Treatment Percentage 2020-2031: Online Sales VS Offline Sales
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Table 1. Global Covid-19 Treatment Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Covid-19 Treatment Market Size Growth by End User (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Covid-19 Treatment Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Covid-19 Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Covid-19 Treatment Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Covid-19 Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Covid-19 Treatment Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Covid-19 Treatment Revenue by End User (2020-2025) & (US$ Million)
Table 9. Global Covid-19 Treatment Revenue Forecast by End User (2026-2031) & (US$ Million)
Table 10. Covid-19 Treatment Revenue by Company (2020-2025) & (US$ Million)
Table 11. Covid-19 Treatment Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Covid-19 Treatment Players by Revenue (US$ Million) in 2024
Table 13. Global Covid-19 Treatment Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Covid-19 Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Treatment as of 2024)
Table 15. Global Covid-19 Treatment Companies Headquarters
Table 16. Date of International Companies Enter into Covid-19 Treatment Market
Table 17. Global Covid-19 Treatment Companies Product & Service
Table 18. Global Covid-19 Treatment Mergers & Acquisitions, Expansion Plans
Table 19. Cadila Healthcare Corporation Information
Table 20. Cadila Healthcare Description and Business Overview
Table 21. Cadila Healthcare Covid-19 Treatment Product
Table 22. Cadila Healthcare Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Cadila Healthcare Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 24. Cadila Healthcare Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 25. Cadila Healthcare Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 26. Cadila Healthcare Recent Developments
Table 27. Johnson & Johnson Corporation Information
Table 28. Johnson & Johnson Description and Business Overview
Table 29. Johnson & Johnson Covid-19 Treatment Product
Table 30. Johnson & Johnson Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Johnson & Johnson Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 32. Johnson & Johnson Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 33. Johnson & Johnson Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 34. Johnson & Johnson Recent Developments
Table 35. ImmunoPrecise Corporation Information
Table 36. ImmunoPrecise Description and Business Overview
Table 37. ImmunoPrecise Covid-19 Treatment Product
Table 38. ImmunoPrecise Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. ImmunoPrecise Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 40. ImmunoPrecise Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 41. ImmunoPrecise Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 42. ImmunoPrecise Recent Developments
Table 43. Novartis Corporation Information
Table 44. Novartis Description and Business Overview
Table 45. Novartis Covid-19 Treatment Product
Table 46. Novartis Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Novartis Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 48. Novartis Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 49. Novartis Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 50. Novartis Recent Developments
Table 51. AstraZeneca Corporation Information
Table 52. AstraZeneca Description and Business Overview
Table 53. AstraZeneca Covid-19 Treatment Product
Table 54. AstraZeneca Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. AstraZeneca Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 56. AstraZeneca Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 57. AstraZeneca Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 58. AstraZeneca Recent Developments
Table 59. Cipla Corporation Information
Table 60. Cipla Description and Business Overview
Table 61. Cipla Covid-19 Treatment Product
Table 62. Cipla Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Cipla Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 64. Cipla Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 65. Cipla Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 66. Cipla Recent Developments
Table 67. AbbVie Corporation Information
Table 68. AbbVie Description and Business Overview
Table 69. AbbVie Covid-19 Treatment Product
Table 70. AbbVie Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. AbbVie Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 72. AbbVie Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 73. AbbVie Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 74. AbbVie Recent Developments
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Covid-19 Treatment Product
Table 78. Bayer Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Bayer Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 80. Bayer Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 81. Bayer Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 82. Bayer Recent Developments
Table 83. Regeneron Pharmaceuticals Corporation Information
Table 84. Regeneron Pharmaceuticals Description and Business Overview
Table 85. Regeneron Pharmaceuticals Covid-19 Treatment Product
Table 86. Regeneron Pharmaceuticals Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Regeneron Pharmaceuticals Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 88. Regeneron Pharmaceuticals Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 89. Regeneron Pharmaceuticals Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 90. Regeneron Pharmaceuticals Recent Developments
Table 91. Ascletis Pharma Corporation Information
Table 92. Ascletis Pharma Description and Business Overview
Table 93. Ascletis Pharma Covid-19 Treatment Product
Table 94. Ascletis Pharma Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Ascletis Pharma Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 96. Ascletis Pharma Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 97. Ascletis Pharma Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 98. Ascletis Pharma Recent Developments
Table 99. GlaxoSmithKline Corporation Information
Table 100. GlaxoSmithKline Description and Business Overview
Table 101. GlaxoSmithKline Covid-19 Treatment Product
Table 102. GlaxoSmithKline Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. GlaxoSmithKline Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 104. GlaxoSmithKline Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 105. GlaxoSmithKline Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 106. GlaxoSmithKline Recent Developments
Table 107. Gilead Sciences Corporation Information
Table 108. Gilead Sciences Description and Business Overview
Table 109. Gilead Sciences Covid-19 Treatment Product
Table 110. Gilead Sciences Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Gilead Sciences Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 112. Gilead Sciences Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 113. Gilead Sciences Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 114. Gilead Sciences Recent Developments
Table 115. Pharmstandard Corporation Information
Table 116. Pharmstandard Description and Business Overview
Table 117. Pharmstandard Covid-19 Treatment Product
Table 118. Pharmstandard Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Pharmstandard Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 120. Pharmstandard Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 121. Pharmstandard Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 122. Pharmstandard Recent Developments
Table 123. Fujifilm Holdings Corporation Information
Table 124. Fujifilm Holdings Description and Business Overview
Table 125. Fujifilm Holdings Covid-19 Treatment Product
Table 126. Fujifilm Holdings Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Fujifilm Holdings Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 128. Fujifilm Holdings Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 129. Fujifilm Holdings Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 130. Fujifilm Holdings Recent Developments
Table 131. Zhejiang Hisun Pharmaceutical Co. Ltd Corporation Information
Table 132. Zhejiang Hisun Pharmaceutical Co. Ltd Description and Business Overview
Table 133. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product
Table 134. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 136. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 137. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 138. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments
Table 139. Roche Corporation Information
Table 140. Roche Description and Business Overview
Table 141. Roche Covid-19 Treatment Product
Table 142. Roche Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Roche Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 144. Roche Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 145. Roche Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 146. Roche Recent Developments
Table 147. Sanofi Corporation Information
Table 148. Sanofi Description and Business Overview
Table 149. Sanofi Covid-19 Treatment Product
Table 150. Sanofi Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Sanofi Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 152. Sanofi Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 153. Sanofi Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 154. Sanofi Recent Developments
Table 155. Pfizer Corporation Information
Table 156. Pfizer Description and Business Overview
Table 157. Pfizer Covid-19 Treatment Product
Table 158. Pfizer Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Pfizer Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 160. Pfizer Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 161. Pfizer Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 162. Pfizer Recent Developments
Table 163. Eli Lilly Corporation Information
Table 164. Eli Lilly Description and Business Overview
Table 165. Eli Lilly Covid-19 Treatment Product
Table 166. Eli Lilly Covid-19 Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
Table 167. Eli Lilly Revenue Proportion of Covid-19 Treatment by Product in 2024
Table 168. Eli Lilly Revenue Proportion of Covid-19 Treatment by End User in 2024
Table 169. Eli Lilly Revenue Proportion of Covid-19 Treatment by Geographic Area in 2024
Table 170. Eli Lilly Recent Developments
Table 171. North America Covid-19 Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 172. North America Covid-19 Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 173. North America Covid-19 Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 174. North America Covid-19 Treatment Revenue by End User (2020-2025) & (US$ Million)
Table 175. Asia-Pacific Covid-19 Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 176. Asia-Pacific Covid-19 Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 177. Asia-Pacific Covid-19 Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 178. Asia-Pacific Covid-19 Treatment Revenue by End User (2020-2025) & (US$ Million)
Table 179. Europe Covid-19 Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 180. Europe Covid-19 Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 181. Europe Covid-19 Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 182. Europe Covid-19 Treatment Revenue by End User (2020-2025) & (US$ Million)
Table 183. Latin America Covid-19 Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 184. Latin America Covid-19 Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 185. Latin America Covid-19 Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 186. Latin America Covid-19 Treatment Revenue by End User (2020-2025) & (US$ Million)
Table 187. Middle East and Africa Covid-19 Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 188. Middle East and Africa Covid-19 Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 189. Middle East and Africa Covid-19 Treatment Revenue by Type (2020-2025) & (US$ Million)
Table 190. Middle East and Africa Covid-19 Treatment Revenue by End User (2020-2025) & (US$ Million)
Table 191. Covid-19 Treatment Key Raw Materials, Industry Status and Trend
Table 192. Covid-19 Treatment Key Raw Materials and Upstream Suppliers
Table 193. Covid-19 Treatment Clients Status and Trend
Table 194. Covid-19 Treatment Typical Clients
Table 195. Covid-19 Treatment Distributors
Table 196. Covid-19 Treatment Market Trends
Table 197. Covid-19 Treatment Market Drivers
Table 198. Covid-19 Treatment Market Challenges
Table 199. Covid-19 Treatment Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Covid-19 Treatment Product Picture
Figure 2. Global Covid-19 Treatment Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Covid-19 Treatment Revenue Market Share by Type in 2024 & 2031
Figure 4. Life Support Product Picture
Figure 5. Antiviral Medicine Product Picture
Figure 6. Antibody Treatments Product Picture
Figure 7. Others Product Picture
Figure 8. Global Covid-19 Treatment Market Size by End User (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Covid-19 Treatment Revenue Market Share by End User in 2024 & 2031
Figure 10. Children
Figure 11. Adult
Figure 12. Covid-19 Treatment Report Years Considered
Figure 13. Global Covid-19 Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Covid-19 Treatment Market Size (2020-2031) & (US$ Million)
Figure 15. Global Covid-19 Treatment Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Covid-19 Treatment Revenue Market Share by Region (2020-2031)
Figure 17. Global Covid-19 Treatment Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Covid-19 Treatment Revenue Market Share Forecast by End User (2020-2031)
Figure 19. Life Support of Covid-19 Treatment Revenue Market Share by End User, 2024 VS 2031
Figure 20. Antiviral Medicine of Covid-19 Treatment Revenue Market Share by End User, 2024 VS 2031
Figure 21. Antibody Treatments of Covid-19 Treatment Revenue Market Share by End User, 2024 VS 2031
Figure 22. Others of Covid-19 Treatment Revenue Market Share by End User, 2024 VS 2031
Figure 23. Covid-19 Treatment Revenue Share by Company (2024)
Figure 24. Covid-19 Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Life Support Revenue Proportion by Company in 2024
Figure 26. Antiviral Medicine Revenue Proportion by Company in 2024
Figure 27. Antibody Treatments Revenue Proportion by Company in 2024
Figure 28. Others Revenue Proportion by Company in 2024
Figure 29. North America Covid-19 Treatment Revenue 2020-2031 (US$ Million)
Figure 30. North America Covid-19 Treatment Revenue Market Share by Type (2020-2025)
Figure 31. North America Covid-19 Treatment Revenue Market Share by End User (2020-2025)
Figure 32. Asia-Pacific Covid-19 Treatment Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Covid-19 Treatment Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Covid-19 Treatment Revenue Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Covid-19 Treatment Revenue Market Share by End User (2020-2025)
Figure 36. Europe Covid-19 Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Covid-19 Treatment Revenue Market Share by Country (2020-2031)
Figure 38. Europe Covid-19 Treatment Revenue Market Share by Type (2020-2025)
Figure 39. Europe Covid-19 Treatment Revenue Market Share by End User (2020-2025)
Figure 40. Latin America Covid-19 Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Latin America Covid-19 Treatment Revenue Market Share by Country (2020-2031)
Figure 42. Latin America Covid-19 Treatment Revenue Market Share by Type (2020-2025)
Figure 43. Latin America Covid-19 Treatment Revenue Market Share by End User (2020-2025)
Figure 44. Middle East and Africa Covid-19 Treatment Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Middle East and Africa Covid-19 Treatment Revenue Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Covid-19 Treatment Revenue Market Share by Type (2020-2025)
Figure 47. Middle East and Africa Covid-19 Treatment Revenue Market Share by End User (2020-2025)
Figure 48. Covid-19 Treatment Supply Chain (Upstream and Downstream Market)
Figure 49. Global Production Market Share of Covid-19 Treatment Raw Materials by Region in 2024
Figure 50. Covid-19 Treatment Distribution Channels
Figure 51. Global Covid-19 Treatment Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 52. Global Covid-19 Treatment Percentage 2020-2031: Online Sales VS Offline Sales
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232